Miso Kim相关文献与解析，生知库 | 链接生命科学的每一步

Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

EGFR酪氨酸激酶抑制剂对EGFR突变非小细胞肺癌肿瘤微环境的重塑

doi:10.1016/j.isci.2024.111736

Soomin Kim, Jaemoon Koh, Tae Min Kim, Songji Oh, Soyeon Kim, Jeonghwan Youk, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Dong-Wan Kim, Dae Seog Heo

Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience

利用机构自主研发的临床靶向测序技术提高乳腺癌患者生存率：七年经验

期刊:Cancer Research and Treatment

影响因子:3.8

doi:10.4143/crt.2024.296

Koh, Jiwon; Kim, Jinyong; Woo, Go-Un; Yi, Hanbaek; Kwon, So Yean; Seo, Jeongmin; Bae, Jeong Mo; Kim, Jung Ho; Won, Jae Kyung; Ryu, Han Suk; Jeon, Yoon Kyung; Lee, Dae-Won; Kim, Miso; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Tae-You; Lee, Jee-Soo; Seong, Moon-Woo; Kim, Sheehyun; Lee, Sungyoung; Yun, Hongseok; Song, Myung Geun; Choi, Jaeyong; Kim, Jong-Il; Im, Seock-Ah

ALK Inhibition in a Patient with Inflammatory Myofibroblastic Tumor Harboring CARS1-ALK Fusion

ALK抑制剂治疗携带CARS1-ALK融合基因的炎性肌纤维母细胞瘤患者

期刊:Cancer Research and Treatment

影响因子:3.8

doi:10.4143/crt.2024.1184

Choi, Songji; Kim, Miso; Kim, Sheehyun; Park, Taekeun; Kwak, Yoonjin; Bae, Jeong Mo; Yun, Hongseok; Kim, Jee Hyun

Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma

肿瘤浸润淋巴细胞和免疫表型对帕博利珠单抗治疗复发或难治性胸腺癌的预测作用

期刊:Journal of Thoracic Disease

影响因子:1.9

doi:10.21037/jtd-2025-526

Kim, Dong Hyun; Lim, Yoojoo; Song, Sanghoon; Ock, Chan-Young; Youk, Jeonghwan; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Kim, Hak Jae; Koh, Jiwon; Jung, Kyeong Cheon; Na, Kwon Joong; Kang, Chang Hyun; Keam, Bhumsuk

Deep Learning Analysis of White Matter Hyperintensity and its Association with Comprehensive Vascular Factors in Two Large General Populations

利用深度学习分析两大普通人群中白质高信号及其与综合血管因素的关联

期刊:

影响因子:

doi:10.1007/s10278-024-01372-8

Lee, Grace Yoojin; Choi, Yun Ho; Kim, Dongwon; Jang, Miso; Kim, Hong-Kyu; Nam, Hyo-Jung; Park, Sungwon; Kim, Mi Jung; Hwang, Yoon Ho; Lee, Seung Ku; Shin, Chol; Kim, Namkug

信号转导

发表日期：2025

文献求助收藏

Risk of Heart Disease in Patients With Amputation: A Nationwide Cohort Study in South Korea

韩国一项全国性队列研究：截肢患者心脏病风险

期刊:Journal of the American Heart Association

影响因子:5.3

doi:10.1161/JAHA.123.033304

Choi, Hea Lim; Yoo, Jung Eun; Kim, Miso; Kim, Bongsung; Park, Junhee; Chang, Won Hyuk; Lee, Heesun; Han, Kyungdo; Shin, Dong Wook

Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis

软组织肉瘤脑转移病例系列及其基因组和转录组分析意义

期刊:Cancer Research and Treatment

影响因子:3.8

doi:10.4143/crt.2023.864

Park, Changhee; Kim, Rokhyun; Choi, Jaeyong; Kim, Miso; Kim, Tae Min; Han, Ilkyu; Kim, Jong-Il; Kim, Han-Soo

神经科学

发表日期：2024

文献求助收藏

Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer

基于NGS的高灵敏度ctDNA检测方法在非小细胞肺癌真实世界中的一致性分析和临床验证

期刊:Cancer Research and Treatment

影响因子:3.8

doi:10.4143/crt.2023.1294

Yi, Hanbaek; Youk, Jeonghwan; Lim, Yoojoo; Roh, Hanseong; Kyung, Dongsoo; Kim, Hwang-Phill; Bang, Duhee; Keam, Bhumsuk; Kim, Tae-Min; Kim, Miso; Kim, Dong-Wan; Kim, Tae-You

Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18

根据 EGFR 和 ALK 状态评估，在不可切除的局部晚期 III 期非小细胞肺癌患者接受根治性同步放化疗后，Durvalumab 维持治疗的临床结果：韩国癌症研究组 LU-22-18

期刊:JTO Clinical and Research Reports

影响因子:3.5

doi:10.1016/j.jtocrr.2024.100734

Choi, Dae-Ho; Kim, Miso; Kim, Young Saing; Park, Keon Uk; Cho, Jang Ho; Kim, Hongsik; Lee, Ki Hyeong; Ahn, Heejoon; Kim, Il-Hwan; Lee, Kyung-Hee; Lee, Gyeong-Won; Yi, Seong Yoon; Ahn, Beung Chul; Lee, Min-Young; Jung, Hyun Ae; Park, Sehhoon; Sun, Jong-Mu; Ahn, Jin Seok; Lee, Se-Hoon; Ahn, Myung-Ju

Wireless Acousto-Piezoelectric Conduit with Aligned Nanofibers for Neural Regeneration

用于神经再生的具有取向纳米纤维的无线声压电导管

Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

EGFR酪氨酸激酶抑制剂对EGFR突变非小细胞肺癌肿瘤微环境的重塑

Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience

利用机构自主研发的临床靶向测序技术提高乳腺癌患者生存率：七年经验

ALK Inhibition in a Patient with Inflammatory Myofibroblastic Tumor Harboring CARS1-ALK Fusion

ALK抑制剂治疗携带CARS1-ALK融合基因的炎性肌纤维母细胞瘤患者

Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma

肿瘤浸润淋巴细胞和免疫表型对帕博利珠单抗治疗复发或难治性胸腺癌的预测作用

Deep Learning Analysis of White Matter Hyperintensity and its Association with Comprehensive Vascular Factors in Two Large General Populations

利用深度学习分析两大普通人群中白质高信号及其与综合血管因素的关联

Risk of Heart Disease in Patients With Amputation: A Nationwide Cohort Study in South Korea

韩国一项全国性队列研究：截肢患者心脏病风险

Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis

软组织肉瘤脑转移病例系列及其基因组和转录组分析意义

Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer

基于NGS的高灵敏度ctDNA检测方法在非小细胞肺癌真实世界中的一致性分析和临床验证

Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18

根据 EGFR 和 ALK 状态评估，在不可切除的局部晚期 III 期非小细胞肺癌患者接受根治性同步放化疗后，Durvalumab 维持治疗的临床结果：韩国癌症研究组 LU-22-18